EICHOR
● Terminated
A Study of JNJ-95475939 in the Treatment of Participants With Moderate to Severe Atopic Dermatitis (AD)
Condition: Dermatitis, Atopic · Sponsor: Janssen Research & Development, LLC
About this study
The purpose of this study is to evaluate how well JNJ-95475939 works as compared to placebo in participants with moderate to severe atopic dermatitis.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (71)
| First OC Dermatology | Fountain Valley, California, United States | — |
| University of California Los Angeles - Division of Dermatology | Los Angeles, California, United States | — |
| Hamilton Research LLC | Alpharetta, Georgia, United States | — |
| DeNova Research | Chicago, Illinois, United States | — |
| Dawes Fretzin Clinical Research Group LLC | Indianapolis, Indiana, United States | — |
| Indiana Clinical Trial Center | Plainfield, Indiana, United States | — |
| Red River Research Partners LLC | Fargo, North Dakota, United States | — |
| Optima Research | Boardman, Ohio, United States | — |
| Oregon Medical Research Center | Portland, Oregon, United States | — |
| Arlington Center for Dermatology | Arlington, Texas, United States | — |
| Center for Clinical Studies | Houston, Texas, United States | — |
| Progressive Clinical Research | San Antonio, Texas, United States | — |
+ 59 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06881251